Hsa_circ_0002577 promotes endometrial carcinoma progression via regulating miR-197/CTNND1 axis and activating Wnt/β-catenin pathway

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstetrics Gynaecol. 2001;15(3):341–354.
   PubMed Web of Science ®Google Scholar
• Hüsing A, Dossus L, Ferrari P, et al. An epidemiological model for prediction of endometrial cancer risk in Europe. Eur J Epidemiol. 2016;31(1):51–60.
   PubMed Web of Science ®Google Scholar
• Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121–127.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19(2):141–157.
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. Rna. 2014;20(12):1829–1842.
   PubMed Web of Science ®Google Scholar
• Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205.
   PubMed Web of Science ®Google Scholar
• Zong L, Sun Q, Zhang H, et al. Increased expression of circRNA_102231 in lung cancer and its clinical significance. Biomed Pharmacother. 2018;102:639–644.
   PubMed Web of Science ®Google Scholar
• Yang P, Qiu Z, Jiang Y, et al. Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway. Oncotarget. 2016;7(39):63449.
   PubMedGoogle Scholar
• Jin C, Wang A, Liu L, et al. Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR‐136/SH2B1 axis. J Cell Physiol. 2019;234(5):7247–7256.
   Web of Science ®Google Scholar
• Xu H, Gong Z, Shen Y, et al. Circular RNA expression in extracellular vesicles isolated from serum of patients with endometrial cancer. Epigenomics. 2018;10(2):187–197.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Conry JA, Blake J, et al. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynecol Obstet. 2015;131(3):219–225.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang F, Chen SJ, et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biol. 2015;36(4):2947–2955.
   PubMedGoogle Scholar
• Yang F, Zhang H, Chen SJ, et al. MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1. PloS One. 2015;10(3):e0120258.
   PubMed Web of Science ®Google Scholar
• Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2017;14(5):514–521.
   PubMed Web of Science ®Google Scholar
• Salzman J, Gawad C, Wang PL, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PloS One. 2012;7(2):e30733.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang D, Long Z, et al. CircRNA8924 promotes cervical Cancer cell proliferation, migration and invasion by competitively binding to MiR-518d-5p/519-5p family and modulating the expression of CBX8. Cell Physiol Biochem. 2018;48(1):173–184.
   PubMedGoogle Scholar
• Hu J, Wang L, Chen J, et al. The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling. Biochem Biophys Res Commun. 2018;505(1):222–228.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang J, He Y, et al. hsa_circ_0061140 knockdown reverses FOXM1-mediated cell growth and metastasis in ovarian cancer through miR-370 sponge activity. Mol Ther Nucleic Acids. 2018;13:55–63.
   PubMedGoogle Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
   PubMed Web of Science ®Google Scholar
• Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metast Rev. 2009;28(3–4):369.
   PubMed Web of Science ®Google Scholar
• Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer. J Pathol. 2011;223(2):102–115.
   PubMed Web of Science ®Google Scholar
• Hu Q, Du K, Mao X, et al. miR-197 is downregulated in cervical carcinogenesis and suppresses cell proliferation and invasion through targeting forkhead box M1. Oncol Lett. 2018;15(6):10063–10069.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao W, Wang Z, et al. Long non‐coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR‐197/LIN28 axis. J Cell Mol Med. 2019;23(1):680–688.
   Web of Science ®Google Scholar
• Reynolds AB, Roesel DJ, Kanner SB, et al. Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol. 1989;9(2):629–638.
   PubMed Web of Science ®Google Scholar
• Shibamoto S, Hayakawa M, Takeuchi K, et al. Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol. 1995;128(5):949–957.
   PubMed Web of Science ®Google Scholar
• Cao N, Mu L, Yang W, et al. MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling. Biomed Pharmacother. 2018;106:483–490.
   PubMed Web of Science ®Google Scholar
• Tang B, Tang F, Wang Z, et al. Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. J Exp Clin Cancer Res. 2016;35(1):82.
   PubMedGoogle Scholar